Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
By Brendan Pierson London: Pfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with rival Teva to delay launching a less expensive generic version of antidepressant Effexor XR, in addition to a $39 million …